 David Randolph
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature, Diseases | 2 | 2014 | 113 | 0.460 |
Why?
| | Th1 Cells | 3 | 2013 | 139 | 0.430 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2014 | 75 | 0.420 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 73 | 0.380 |
Why?
| | Acidosis | 1 | 2014 | 105 | 0.380 |
Why?
| | Neonatal Screening | 1 | 2014 | 179 | 0.360 |
Why?
| | Tretinoin | 1 | 2013 | 125 | 0.360 |
Why?
| | Cytomegalovirus Infections | 1 | 2014 | 206 | 0.350 |
Why?
| | Developmental Disabilities | 1 | 2014 | 281 | 0.330 |
Why?
| | Th17 Cells | 1 | 2011 | 102 | 0.330 |
Why?
| | Nervous System Diseases | 1 | 2014 | 286 | 0.330 |
Why?
| | Immune Tolerance | 1 | 2013 | 385 | 0.320 |
Why?
| | Cell Movement | 3 | 2013 | 961 | 0.320 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2011 | 910 | 0.310 |
Why?
| | Hypersensitivity | 1 | 2013 | 254 | 0.310 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2014 | 440 | 0.290 |
Why?
| | Graft vs Host Disease | 2 | 2013 | 279 | 0.270 |
Why?
| | Premature Birth | 1 | 2011 | 390 | 0.260 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2006 | 68 | 0.220 |
Why?
| | Immunity, Cellular | 1 | 2006 | 274 | 0.200 |
Why?
| | Cytokines | 1 | 2011 | 2069 | 0.200 |
Why?
| | T-Lymphocyte Subsets | 1 | 2006 | 420 | 0.200 |
Why?
| | Computer Security | 2 | 2021 | 25 | 0.200 |
Why?
| | Infant, Newborn | 8 | 2014 | 6464 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2006 | 411 | 0.180 |
Why?
| | Spleen | 2 | 2013 | 508 | 0.160 |
Why?
| | Health Facilities | 1 | 2021 | 85 | 0.160 |
Why?
| | Multiple Sclerosis | 1 | 2006 | 489 | 0.160 |
Why?
| | Privacy | 1 | 2020 | 41 | 0.150 |
Why?
| | Medical Records Systems, Computerized | 1 | 2020 | 95 | 0.150 |
Why?
| | Interferon-gamma | 2 | 2013 | 784 | 0.150 |
Why?
| | Medical Record Linkage | 1 | 2020 | 69 | 0.150 |
Why?
| | Dysbiosis | 1 | 2019 | 188 | 0.130 |
Why?
| | Animals, Newborn | 3 | 2019 | 896 | 0.120 |
Why?
| | Incidence | 2 | 2014 | 2933 | 0.120 |
Why?
| | Point Mutation | 2 | 2007 | 241 | 0.120 |
Why?
| | Algorithms | 3 | 2020 | 1850 | 0.110 |
Why?
| | Candidiasis, Invasive | 1 | 2014 | 6 | 0.110 |
Why?
| | Fluconazole | 1 | 2014 | 24 | 0.100 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2014 | 24 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2021 | 947 | 0.100 |
Why?
| | Infant, Premature | 2 | 2019 | 620 | 0.100 |
Why?
| | Red-Cell Aplasia, Pure | 1 | 2013 | 1 | 0.100 |
Why?
| | Antifungal Agents | 1 | 2014 | 152 | 0.100 |
Why?
| | Chemokines | 3 | 2009 | 217 | 0.100 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2013 | 35 | 0.100 |
Why?
| | Sepsis | 1 | 2019 | 664 | 0.100 |
Why?
| | Thienamycins | 1 | 2012 | 3 | 0.090 |
Why?
| | Intraabdominal Infections | 1 | 2012 | 12 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 532 | 0.090 |
Why?
| | Th1-Th2 Balance | 1 | 2011 | 8 | 0.090 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2011 | 14 | 0.090 |
Why?
| | Receptors, Interleukin | 1 | 2011 | 43 | 0.090 |
Why?
| | Thymus Gland | 1 | 2013 | 312 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 209 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2013 | 1261 | 0.090 |
Why?
| | Fetal Blood | 1 | 2014 | 327 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2013 | 509 | 0.090 |
Why?
| | Bone Marrow Cells | 1 | 2013 | 322 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 768 | 0.090 |
Why?
| | Th2 Cells | 2 | 2002 | 175 | 0.090 |
Why?
| | Bone Marrow | 1 | 2013 | 307 | 0.080 |
Why?
| | T-Box Domain Proteins | 1 | 2011 | 106 | 0.080 |
Why?
| | Cell Separation | 1 | 2011 | 306 | 0.080 |
Why?
| | Pattern Recognition, Automated | 2 | 2007 | 74 | 0.080 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 206 | 0.080 |
Why?
| | Autoantigens | 1 | 2013 | 427 | 0.080 |
Why?
| | Jejunum | 1 | 2009 | 37 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2191 | 0.070 |
Why?
| | Hospital Mortality | 1 | 2014 | 1038 | 0.070 |
Why?
| | Chemotaxis | 1 | 2009 | 122 | 0.070 |
Why?
| | Time Factors | 2 | 2013 | 7133 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2006 | 3937 | 0.070 |
Why?
| | Antigens, CD | 1 | 2011 | 558 | 0.070 |
Why?
| | Ileum | 1 | 2009 | 112 | 0.070 |
Why?
| | Interleukin-8 | 1 | 2009 | 269 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2011 | 1165 | 0.070 |
Why?
| | Humans | 14 | 2021 | 145750 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2013 | 3130 | 0.060 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2006 | 45 | 0.060 |
Why?
| | Receptors, Interleukin-2 | 1 | 2006 | 64 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2011 | 4151 | 0.060 |
Why?
| | Computational Biology | 2 | 2007 | 669 | 0.060 |
Why?
| | Prognosis | 1 | 2014 | 4329 | 0.050 |
Why?
| | Registries | 1 | 2014 | 2410 | 0.050 |
Why?
| | Mice | 5 | 2019 | 18357 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2006 | 440 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5428 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2013 | 5992 | 0.050 |
Why?
| | Respirovirus Infections | 1 | 2002 | 14 | 0.050 |
Why?
| | Epithelial Cells | 1 | 2009 | 1134 | 0.050 |
Why?
| | Pulmonary Eosinophilia | 1 | 2002 | 27 | 0.040 |
Why?
| | Adult | 4 | 2014 | 40867 | 0.040 |
Why?
| | Ovalbumin | 1 | 2002 | 194 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2002 | 174 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 1925 | 0.040 |
Why?
| | Macrophages | 1 | 2009 | 1507 | 0.040 |
Why?
| | Animals | 6 | 2019 | 38100 | 0.040 |
Why?
| | Pregnancy | 1 | 2014 | 7215 | 0.040 |
Why?
| | Female | 6 | 2014 | 79025 | 0.040 |
Why?
| | Protective Agents | 1 | 2019 | 42 | 0.040 |
Why?
| | Software | 2 | 2020 | 680 | 0.040 |
Why?
| | Confidentiality | 1 | 2020 | 80 | 0.040 |
Why?
| | Risk Factors | 1 | 2014 | 10916 | 0.040 |
Why?
| | Probiotics | 1 | 2019 | 61 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 431 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2002 | 396 | 0.030 |
Why?
| | Signal Transduction | 1 | 2011 | 5223 | 0.030 |
Why?
| | Age of Onset | 1 | 2019 | 557 | 0.030 |
Why?
| | Young Adult | 1 | 2014 | 14250 | 0.030 |
Why?
| | Databases, Genetic | 2 | 2007 | 238 | 0.030 |
Why?
| | United States | 1 | 2014 | 16122 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 4090 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2014 | 17322 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2014 | 318 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 2014 | 156 | 0.020 |
Why?
| | Infant Mortality | 1 | 2014 | 128 | 0.020 |
Why?
| | Histocompatibility Testing | 1 | 2013 | 123 | 0.020 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 91 | 0.020 |
Why?
| | Lung | 2 | 2002 | 4116 | 0.020 |
Why?
| | Major Histocompatibility Complex | 1 | 2013 | 233 | 0.020 |
Why?
| | Male | 3 | 2014 | 72992 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2009 | 1723 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 419 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3752 | 0.020 |
Why?
| | Models, Animal | 1 | 2013 | 393 | 0.020 |
Why?
| | Cell Communication | 1 | 2013 | 328 | 0.020 |
Why?
| | Asthma | 1 | 2002 | 1797 | 0.020 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2014 | 293 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2009 | 44 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2009 | 79 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 112 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4569 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1350 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1478 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 376 | 0.020 |
Why?
| | Databases, Bibliographic | 1 | 2007 | 30 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2009 | 399 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 979 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2007 | 66 | 0.020 |
Why?
| | Databases, Protein | 1 | 2007 | 88 | 0.020 |
Why?
| | Publications | 1 | 2007 | 47 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 849 | 0.020 |
Why?
| | Natural Language Processing | 1 | 2007 | 106 | 0.010 |
Why?
| | Swine | 1 | 2009 | 826 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2007 | 410 | 0.010 |
Why?
| | Monocytes | 1 | 2009 | 539 | 0.010 |
Why?
| | Critical Illness | 1 | 2012 | 900 | 0.010 |
Why?
| | Gestational Age | 1 | 2009 | 989 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2131 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2883 | 0.010 |
Why?
| | Fetus | 1 | 2009 | 804 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1247 | 0.010 |
Why?
| | Inflammation | 2 | 2009 | 2883 | 0.010 |
Why?
| | Neutrophils | 1 | 2009 | 1125 | 0.010 |
Why?
| | Antigens, T-Independent | 1 | 2002 | 5 | 0.010 |
Why?
| | Sendai virus | 1 | 2002 | 6 | 0.010 |
Why?
| | Lymphocyte Cooperation | 1 | 2002 | 50 | 0.010 |
Why?
| | Interleukin-5 | 1 | 2002 | 39 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 2002 | 165 | 0.010 |
Why?
| | Janus Kinase 3 | 1 | 2002 | 19 | 0.010 |
Why?
| | Hypersensitivity, Delayed | 1 | 2002 | 29 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 42 | 0.010 |
Why?
| | Chimera | 1 | 2002 | 61 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 6032 | 0.010 |
Why?
| | Proteins | 1 | 2007 | 1023 | 0.010 |
Why?
| | Immunophenotyping | 1 | 2002 | 322 | 0.010 |
Why?
| | Immunoglobulins | 1 | 2002 | 163 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2805 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 258 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 408 | 0.010 |
Why?
| | Up-Regulation | 1 | 2002 | 848 | 0.010 |
Why?
| | Eosinophils | 1 | 2002 | 316 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2007 | 3416 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2002 | 1133 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 2002 | 435 | 0.010 |
Why?
| | Infant | 1 | 2012 | 10089 | 0.010 |
Why?
|
|
Randolph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|